What has been going on?

More awareness will lead to greater action to control and eliminate schistosomiasis. Have a look at how we have created awareness of this disease.

Partnership with The END Fund

Annually, an estimated 4.3 million people in Rwanda require preventive treatment for schistosomiasis. To bolster Rwanda’s plan to end schistosomiasis by 2024, we will provide Rwanda, in partnership with The END Fund, with 8 million additional tablets of the standard medication for the treatment of schistosomiasis per year. The tablets are needed for treating adults endangered by schistosomiasis and will complement our annual donation for the treatment of school-aged children. The END Fund has been a key partner for the Rwandan national strategic plan for neglected tropical diseases (NTDs) in the past and continues to do so through its Deworming Innovation Fund.
Learn more here!

The NALA Foundation has been a long-time partner in our efforts to eliminate schistosomiasis in Ethiopia. In response to Covid-19 pandemic, NALA immediately mobilized all its resources on the ground to strengthen the local health system. To support their efforts, we have donated 90,000 FFP2-masks which were distributed to community health workers and the education systems.

Learn more

Pediatric Praziquantel Consortium Program

The Pediatric Praziquantel Consortium is an international public-private partnership dedicated to the development of a pediatric formulation to treat schistosomiasis in preschool-age children.  The program is in Clinical Phase III stage to acquire confirmatory data for registration.
In early 2021, the Pediatric Praziquantel Consortium celebrated the official launch of its ADOPT program – an implementation research program for approaches for acceptance and equitable access to the pediatric treatment across endemic countries, once it will be registered.
ADOPT: Virtual Launch
Event:  here

Rapid Diagnostic Tests (RDT) are urgently needed to simplify testing and guide deployment of treatment campaigns in community settings in Africa. A global health strategic partnership we are member of, is developing and validating an innovative RDT for schistosomiasis.

Learn more

Bilharzia Storytelling Lab Kenya

While prevention and control programs have been rolled out in Kenya – including the distribution of medicine – there are still too many people unaware of how to prevent schistosomiasis. During the online workshop, we developed together with Kenyan community leaders and storytellers innovative communication solutions that can creatively improve awareness and access to information. Besides hosting the lab, we are providing seed funding to support the implementation of the best solution.  

Every year on January 30th is World NTD Day! Neglected tropical diseases (NTDs) affect more than 1 billion people in the poorest and most marginalized communities worldwide with devastating health, social and economic consequences. World NTD Day marks an annual opportunity to mobilize together with more than 230 partners greater attention and to celebrate hard-earned progress.
Specially on World NTD Day we want to showcase our commitment to fight against schistosomiasis. Catch a glimpse of our engagement!

Learn more

Nala Partnership extended

We have renewed our partnership with the NALA Foundation – which stands for Neglected Tropical Disease (NTD) Advocacy, Learning, Action – and the Federal Ministry of Health of Ethiopia until 2023 to fight the NTD Schistosomiasis in south-western Ethiopia. Through this project, we will continue to expand our efforts to reach more than 170,000 school-age children in six districts with the highest prevalence of schistosomiasis. Additionally, we will seek to reach 50,000 community members in 8,000 households.    

We have entered into an agreement with Janssen Pharmaceutica, N.V. (company of Johnson and Johnson) to develop an artificial intelligence-based diagnostic tool to improve the detection of the Neglected Tropical Diseases schistosomiasis and soil-transmitted helminthiasis.

read more

Celebrating ten years of donating tablets to WHO for African countries. To mark the milestone moment in the history of schistosomiasis –– a giant worm was placed on Lake Geneva in 2017. The idea behind the worm was to attract global attention to the disease. Since then the worm appeared on many different occasions. Stay tuned where it appears next.

  • What is Schistosomiasis?

    Schistosomiasis is a water-borne tropical disease caused by parasitic worms. Click below to learn more about it.

    learn more
  • Living our Commitment

    More than a decade ago we committed ourselves to the fight against schistosomiasis. Learn more about our efforts to eliminate the disease.

    learn more
  • R&D for schistosomiasis

    We drive and implement R&D programs for innovative drugs, highly sensitive diagnostics, new technologies for safe water access and for controlling transmission of the disease.

    Learn more